Most longevity supplements have mechanistic hypotheses and animal data. Urolithin A is unusual: Timeline Nutrition has published randomized controlled trials in humans showing mitophagy induction, improved muscle endurance, and better mitochondrial function. Here's the complete evidence review.
Most longevity supplements have a pattern: animal data → mechanistic hypothesis → extrapolated human promise → product. Urolithin A breaks this pattern. Timeline Nutrition — the company behind Mitopure, the most studied urolithin A product — has published multiple randomized controlled trials in humans. They have measured mitophagy induction directly, shown improvements in muscle endurance and strength, and demonstrated biomarker changes consistent with improved mitochondrial function. This is unusual in the supplement industry.
Here is the complete evidence review, the mechanism, what the trials actually show, and how to choose between the available urolithin A products.
Urolithin A is a metabolite produced when gut bacteria ferment ellagitannins — polyphenols found in pomegranates, walnuts, and some berries. The production is gut-microbiome dependent: only about 40% of people have the right bacterial populations to produce urolithin A from pomegranate consumption alone. The rest get no urolithin A from food regardless of how much pomegranate they eat.
This microbiome dependency explains why direct urolithin A supplementation was developed — bypassing the gut bacteria step entirely to deliver urolithin A directly.
Mitophagy is the selective autophagy (cellular self-cleaning) of damaged or dysfunctional mitochondria. Healthy cells continuously produce new mitochondria (mitogenesis) and clear out old, inefficient ones (mitophagy). With aging, mitophagy becomes impaired — damaged mitochondria accumulate, reducing cellular energy production and increasing oxidative stress. Mitochondrial dysfunction is one of the 12 hallmarks of aging identified in the 2023 updated framework.